腹主动脉瘤腔内修复术后移植物感染的系统综述与荟萃分析
该系统综述与荟萃分析纳入12项研究共362例患者,评估EVAR术后主动脉移植物感染的结局。结果显示移植物感染发生率为0.6%,30天/住院死亡率为26.6%,保守治疗者30天/住院死亡率达63.3%。完全移除感染移植物并外科重建可能是优选处理策略。
要点
- EVAR术后移植物感染发生率为0.6%(95%CI 0.4%~0.8%)。
- 30天/住院死亡率为26.6%(95%CI 16.9%~39.2%),保守治疗者达63.3%。
- 多数患者接受外科治疗(81%),完全移除感染移植物并重建可能是优选策略。
核心结论
- 主动脉移植物感染是EVAR术后罕见并发症,外科治疗并完全移除感染移植物似乎是优选处理策略。
- 未行外科干预的保守治疗与显著相关死亡率有关。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed/MEDLINE、SCOPUS、CENTRAL及参考文献列表。
- 纳入12项研究共362例患者,平均年龄72岁,其中279例为男性。
- 采用Newcastle-Ottawa量表评估方法学质量,并在PROSPERO注册(CRD42016034166)。
主要发现
- EVAR术后移植物感染发生率为0.6%(95%CI 0.4%~0.8%)。
- 从植入到诊断的时间范围为1至128个月(平均25个月)。
- 81%(293例,95%CI 77%~83%)患者接受外科治疗,2.5%(9例,95%CI 21%~43%)接受保守治疗。
- 主动脉重建方式中,人工血管置换占58%(95%CI 52%~62%),冷冻保存同种血管占31%(95%CI 28%~33%),自体血管占11%(95%CI 8%~14%)。
- 30天/住院死亡率汇总为26.6%(95%CI 16.9%~39.2%),保守治疗9例为63.3%(95%CI 30.7%~87.0%)。
临床怎么用
- 对于EVAR术后移植物感染,在合适患者中应优先考虑外科治疗并完全移除感染移植物。
- 保守治疗与高死亡率相关,决策时需充分评估风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report a meta-analysis of the published evidence on the outcomes of aortic endograft infection after endovascular aneurysm repair (EVAR). METHODS: A search of electronic information sources (PubMed/MEDLINE, SCOPUS, CENTRAL) and bibliographic reference lists identified 12 studies reporting on 362 patients (mean age 72 years; 279 men). The methodological quality of the selected studies was assessed using the Newcastle-Ottawa scale. Endpoints were 30-day/in-hospital mortality and follow-up mortality. Pooled estimates are reported with the 95% confidence interval (CI). The review was registered at the International Prospective Register of Systematic Reviews in Health and Social Care (CRD42016034166). RESULTS: The incidence of graft infection after EVAR was 0.6% (95% CI 0.4% to 0.8%). The time from implantation to diagnosis ranged from 1 to 128 months (mean 25). The majority of patients (293, 81%) underwent surgical treatment (95% CI 77% to 83%); 9 (2.5%) patients (95% CI 21% to 43%) received conservative treatment. Aortic replacement with a prosthetic graft was performed in 58% (95% CI 52% to 62%), whereas cryopreserved allografts and autologous grafts were used in 31% (95% CI 28% to 33%) and 11% (95% CI% 8 to 14%), respectively. Less than half of the patients (40%) had emergency surgery. The pooled estimate of 30-day/in-hospital mortality was 26.6% (95% CI 16.9% to 39.2%). The pooled 30-day/in-hospital mortality for 9 patients treated conservatively was 63.3% (95% CI 30.7% to 87.0%). The pooled overall follow-up mortality was 45.7% (95% CI 36.4% to 55.4%) vs 58.6% (95% CI 28.8% to 83.3%) for the 9 patients receiving conservative treatment. CONCLUSION: Aortic endograft infection is a rare complication after EVAR. Surgical treatment with complete explantation of the infected endograft seems to be the optimal management in selected patients. Supportive medical treatment without surgical intervention has a significant associated mortality.
引用
- Argyriou C, Georgiadis GS, Lazarides MK, et al. Endograft Infection After Endovascular Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis. J Endovasc Ther. 2017. PMID: 28756719. doi:10.1177/1526602817722018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。